Smokers face higher risk of TCC after radiation

Vancouver, British Columbia--It's known that smoking increases the risk of transitional cell carcinoma by approximately two to three times over the baseline rate. Researchers now say that pelvic radiation may further increase the risk of TCC in smokers.

Related Videos

Related Content

Advertisement

December 2nd 2024

Ralph Miller, MD, on the state of HIFU in prostate cancer

Ralph J. Miller Jr, MD

"Most of the published data about HIFU tended to be with relatively short-term follow-up," says Ralph J. Miller Jr, MD.

November 27th 2024

Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

November 27th 2024

Final rule: Conversion factor set for 2.83% reduction in 2025

Jonathan Rubenstein, MD Mark Painter

"The final rule for 2025 poses several challenges to urology. Lobbying efforts to preserve telehealth access and the CF will continue, perhaps dragging into 2025," write Jonathan Rubenstein, MD, and Mark Painter.

November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

November 26th 2024

UGN-101 demonstrates long-term durability in low-grade UTUC

Hannah Clarke

“The median DOR of 47.8 months in patients who achieved complete response with JELMYTO provides evidence of robust durability in maintaining control of low-grade UTUC over an extended period,” says Phillip Pierorazio, MD.

November 25th 2024

Behavioral intervention may improve psychological distress after testicular cancer

Hannah Clarke

The study showed significant reductions in both anxiety and depressive symptoms following the intervention.

Related Content

Advertisement

December 2nd 2024

Ralph Miller, MD, on the state of HIFU in prostate cancer

Ralph J. Miller Jr, MD

"Most of the published data about HIFU tended to be with relatively short-term follow-up," says Ralph J. Miller Jr, MD.

November 27th 2024

Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

November 27th 2024

Final rule: Conversion factor set for 2.83% reduction in 2025

Jonathan Rubenstein, MD Mark Painter

"The final rule for 2025 poses several challenges to urology. Lobbying efforts to preserve telehealth access and the CF will continue, perhaps dragging into 2025," write Jonathan Rubenstein, MD, and Mark Painter.

November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

November 26th 2024

UGN-101 demonstrates long-term durability in low-grade UTUC

Hannah Clarke

“The median DOR of 47.8 months in patients who achieved complete response with JELMYTO provides evidence of robust durability in maintaining control of low-grade UTUC over an extended period,” says Phillip Pierorazio, MD.

November 25th 2024

Behavioral intervention may improve psychological distress after testicular cancer

Hannah Clarke

The study showed significant reductions in both anxiety and depressive symptoms following the intervention.